NSE · EMCURE
Emcure Pharmaceuticals Limited (EMCURE) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#223
of 5,047 stocks
🏆 New peak
▲ 31W▲ 281M
Peak #223 · 17 Nov 2026
A largecap name in Healthcare, Emcure Pharmaceuticals Limited carries a steep earnings multiple that prices in strong future growth, remains firmly promoter-controlled, with promoters holding 78%, and is growing revenue at a solid clip.
Market Cap
44,369.61 Cr
P/E Ratio
47.96
P/B Ratio
8.91
ROE
18.91%
ROCE
25.65%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 2,820.47 Cr | 2,580.45 Cr | 2,469.70 Cr | 2,363.48 Cr |
| Net Profit | 325.07 Cr | 292.49 Cr | 243.74 Cr | 231.37 Cr |
| EPS | 17.16 | 15.50 | 12.84 | 12.16 |
| Operating Profit | 481.43 Cr | 425.06 Cr | 377.28 Cr | 389.92 Cr |
Shareholding pattern
Promoter
77.83%
Public
22.17%
PUBLIC BREAKDOWN
FII
4.88%
DII
8.46%
MF (within DII)
6.87%
Individuals
7.20%
Mutual fund holdings
₹1,657.79
Cr total
68
Schemes
20
Fund Houses
₹1,657.79 Cr
Total Exposure
Aditya Birla Sun Life Mutual Fund₹515.46 Cr (31.1%)
Nippon India Mutual Fund₹375.31 Cr (22.6%)
SBI Mutual Fund₹217.85 Cr (13.1%)
Axis Mutual Fund₹207.30 Cr (12.5%)
HSBC Mutual Fund₹165.61 Cr (10.0%)
Others₹176.27 Cr (10.6%)
| Scheme | Fund House | Value (Cr) | % |
|---|
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 14 Aug 2025 | Dividend | Dividend - Rs 3 Per Share |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.